For International Women's Day 2025, we highlight the need for equity of care for women with a bleeding disorder
On Rare Disease Day 2025, we share the story of an inspirational young woman from Nigeria with Glanzmann thrombasthenia
Parents Lauren and Ben discuss early struggles with haemophilia treatment, and overcoming fear, stress and anxiety
Haemnet's CEO reviews a recent pilot study on how having a bleeding disorder impacts working life
Anna discusses her experience of adapting to a different way of life following an unexpected diagnosis
Through affected in roughly equal numbers, our study findings suggest Glanzmann thrombasthenia impacts women more than men
Our GT360 study is the largest study to date exploring the lived experience of Glanzmann thrombasthenia
Recently, members of the Haemnet team took part in a collaborative event for the von Willebrand's community
Von Willebrand disease is by far the most common bleeding disorder, but it's also one of the least well understood
Who says people with bleeding disorders have unmet need? And how do we decide what it is?
In the world of journal publishing, peer review is used to decide whether a paper is suitable for publication
We look at why sharing experience is important for von Willebrand disease research